Brad Barnett
Chief Tech/Sci/R&D Officer chez COGENT BIOSCIENCES, INC.
Postes actifs de Brad Barnett
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| COGENT BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | - | - |
Historique de carrière de Brad Barnett
Anciens postes connus de Brad Barnett
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ARRAY TECHNOLOGIES, INC. | Corporate Officer/Principal | 01/03/2015 | 01/08/2019 |
Formation de Brad Barnett
| Colorado State University | Undergraduate Degree |
| The University of Colorado | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Masters Business Admin | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| COGENT BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
- Bourse
- Insiders
- Brad Barnett
- Expérience
